Human cord blood CD133+ cells exacerbate ischemic acute kidney injury in mice

Nephrology Dialysis Transplantation

Volumn 27, Issue 10, 2012, Pages 3781-3789

  Burger, Dylan ^a   Gutsol, Alex ^a   Carter, Anthony ^a   Allan, David S ^b   Touyz, Rhian M ^a   Burns, Kevin D ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

acute kidney injury; apoptosis; inflammation; ischemia reperfusion; stem cells

Indexed keywords

CD133 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UREA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD133+ PROGENITOR CELL; CELL ACTIVITY; CELL FUNCTION; CELL INFILTRATION; CELL PROLIFERATION; CELL THERAPY; CELL TYPE; CHEMICAL ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; HISTOLOGY; HUMAN; HUMAN CELL; KIDNEY ISCHEMIA; KIDNEY TUBULE CELL; KIDNEY TUBULE NECROSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; UREA BLOOD LEVEL;

ACUTE KIDNEY INJURY; ANIMALS; ANTIGENS, CD; APOPTOSIS; CELL PROLIFERATION; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOKINES; FETAL BLOOD; GLYCOPROTEINS; HUMANS; INFLAMMATION MEDIATORS; KIDNEY; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEUTROPHILS; PEPTIDES; PEROXIDASE; REPERFUSION INJURY; TRANSPLANTATION, HETEROLOGOUS;

EID: 84868526727     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs110     Document Type: Article

References (42)

1. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930-936
2. Uchino S, Bellomo R, Goldsmith D et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006; 34: 1913-1917
3. Liano F, Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Kidney Int 1996; 50: 811-818
4. Basile DP. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int 2007; 72: 151-156
5. Munshi R, Hsu C, Himmelfarb J. Advances in understanding ischemic acute kidney injury. BMC Med 2011; 9: 11
6. Haller H, Dragun D, Miethke A et al. Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int 1996; 50: 473-480
7. Leonard EC, Friedrich JL, Basile DP. VEGF-121 preserves renal microvessel structure and ameliorates secondary renal disease following acute kidney injury. Am J Physiol Renal Physiol 2008; 295: F1648-F1657
8. Humphreys BD, Bonventre JV. Mesenchymal stem cells in acute kidney injury. Annu Rev Med 2008; 59: 311-325
9. Lin F. Stem cells in kidney regeneration following acute renal injury. Pediatr Res 2006; 59(4 Pt 2): 74R-78R
10. Patschan D, Patschan S, Muller GA. Endothelial progenitor cells in acute ischemic kidney injury: strategies for increasing the cells' renoprotective competence. Int J Nephrol 2011; 2011: 828369
11. Eliopoulos N, Zhao J, Bouchentouf M et al. Human marrowderived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection. Am J Physiol Renal Physiol 2010; 299: F1288-F1298
12. Li B, Cohen A, Hudson TE et al. Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury. Circulation 2010; 121: 2211-2220
13. Brodsky SV, Yamamoto T, Tada T et al. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 2002; 282: F1140-F1149
14. Mizrak D, Brittan M, Alison MR. CD133: molecule of the moment. J Pathol 2008; 214: 3-9
15. Ma N, Ladilov Y, Kaminski A et al. Umbilical cord blood cell transplantation for myocardial regeneration. Transplant Proc 2006; 38: 771-773
16. Stamm C, Kleine HD, Choi YH et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 2007; 133: 717-725
17. Bakondi B, Shimada IS, Perry A et al. CD133 identifies a human bone marrow stem/progenitor cell sub-population with a repertoire of secreted factors that protect against stroke. Mol Ther 2009; 17: 1938-1947
18. Finney MR, Fanning LR, Joseph ME et al. Umbilical cord bloodselected CD133(+) cells exhibit vasculogenic functionality in vitro and in vivo. Cytotherapy 2010; 12: 67-78
19. Burger D, Montezano AC, Nishigaki N et al. Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/rho kinase pathways targeted to lipid rafts. Arterioscler Thromb Vasc Biol 2011; 31: 1898-1907
20. Callera GE, Montezano AC, Touyz RM et al. ETA receptor mediates altered leukocyte-endothelial cell interaction and adhesion molecules expression in DOCA salt rats. Hypertension 2004; 43: 872-879
21. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984; 87: 1344-1350
22. Senegaglia AC, Barboza LA, Dallagiovanna B et al. Are purified or expanded cord blood-derived CD133+ cells better at improving cardiac function?. Exp Biol Med (Maywood) 2010; 235: 119-129
23. Horbelt M, Lee SY, Mang HE et al. Acute and chronic microvascular alterations in a mouse model of ischemic acute kidney injury. Am J Physiol Renal Physiol 2007; 293: F688-F695
24. Lee PT, Lin HH, Jiang ST et al. Mouse kidney progenitor cells accelerate renal regeneration and prolong survival after ischemic injury. Stem Cells 2010; 28: 573-584
25. Rabb H, Daniels F, O'Donnell M et al. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 2000; 279: F525-F531
26. Cao H, Qian H, Xu Wet al. Mesenchymal stem cells derived from human umbilical cord ameliorate ischemia/reperfusion-induced acute renal failure in rats. Biotechnol Lett 2010; 32: 725-732
27. Lin F, Cordes K, Li L et al. Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 2003; 14: 1188-1199
28. Patschan D, Patschan S, Wessels JT et al. Epac-1 activator 8-OcAMP augments renoprotective effects of syngeneic [corrected] murine EPCs in acute ischemic kidney injury. Am J Physiol Renal Physiol 2010; 298: F78-F85
29. Feng Z, Ting J, Alfonso Z et al. Fresh and cryopreserved, uncultured adipose tissue-derived stem and regenerative cells ameliorate ischemia-reperfusion-induced acute kidney injury. Nephrol Dial Transplant 2010; 25: 3874-3884
30. Perin L, Sedrakyan S, Giuliani S et al. Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One 2010; 5: e9357
31. Wang PH, Schwindt TT, Barnabe GF et al. Administration of neural precursor cells ameliorates renal ischemia-reperfusion injury. Nephron Exp Nephrol 2009; 112: e20-e28
32. Suuronen EJ, Veinot JP, Wong S et al. Tissue-engineered injectable collagen-based matrices for improved cell delivery and vascularization of ischemic tissue using CD133+ progenitors expanded from the peripheral blood. Circulation 2006; 114 (1 Suppl): 1138-1144
33. Lopez-Holgado N, Alberca M, Sanchez-Guijo FM et al. Prospective comparative analysis of the angiogenic capacity of monocytes and CD133+ cells in a murine model of hind limb ischemia. Cytotherapy 2009; 11: 1041-1051
34. Barcelos LS, Duplaa C, Krankel N et al. Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res 2009; 104: 1095-1102
35. Bartunek J, Vanderheyden M, Vandekerckhove B et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction. Circulation 2005; 1129 SupplI-178-I-183
36. George J, Afek A, Abashidze A et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2005; 25: 2636-2641
37. Langwieser N, Schwarz JB, Reichenbacher C et al. Role of bone marrow-derived cells in the genetic control of restenosis. Arterioscler Thromb Vasc Biol 2009; 29: 1551-1557
38. Sepp D, Esposito L, Zepper P et al. Surface expression of CXCR4 on circulating CD133progenitor cells is associated with plaque instability in subjects with carotid artery stenosis. J Angiogenes Res 2009; 1: 10
39. Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 2004; 61: 461-470
40. Crop MJ, Korevaar SS, de Kuiper R et al. Human mesenchymal stem cells are susceptible to lysis by CD8+ T-cells and NK cells. Cell Transplant 2011; 20: 1547-1559
41. Ramesh G, Reeves WB. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Am J Physiol Renal Physiol 2003; 285: F610-F618
42. Cunningham PN, Dyanov HM, Park P et al. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002; 168: 5817-5823